LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00033333
 50.36 84.90 4913 5651 0.8694 0.9543
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 52.06 84.90 702 5990 0.1172 0.4106
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 52.06 84.90 4153 5990 0.6932 0.8842
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 52.06 84.90 449 5990 0.0749 0.3116
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 52.06 84.90 5140 5990 0.8580 0.9507
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 53.77 84.90 820 6252 0.1311 0.4414
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 53.77 84.90 4404 6252 0.7043 0.8901
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 53.77 84.90 489 6252 0.0782 0.3262
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 53.77 84.90 5473 6252 0.8753 0.9575
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 55.48 84.90 885 6567 0.1348 0.4530
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 55.48 84.90 4607 6567 0.7015 0.8901
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 55.48 84.90 465 6567 0.0708 0.3114
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 55.48 84.90 5769 6567 0.8784 0.9591
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 57.18 84.90 960 6963 0.1379 0.4645
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 57.18 84.90 4820 6963 0.6922 0.8876
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 57.18 84.90 529 6963 0.0760 0.3334
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 57.18 84.90 6082 6963 0.8734 0.9579
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 58.88 84.90 1012 7291 0.1388 0.4707
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 58.88 84.90 5086 7291 0.6975 0.8909
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 58.88 84.90 526 7291 0.0721 0.3283
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 58.88 84.90 6296 7291 0.8634 0.9548
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 60.59 84.90 1031 7641 0.1349 0.4690
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 60.59 84.90 5253 7641 0.6874 0.8878
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 60.59 84.90 588 7641 0.0769 0.3473
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 60.59 84.90 6566 7641 0.8592 0.9538
MN20160318_Q02
E21